Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Finished Goods (2016 - 2019)

Cryo Cell International (CCEL) has disclosed Finished Goods for 5 consecutive years, with $74290.0 as the latest value for Q1 2019.

  • On a quarterly basis, Finished Goods fell 69.85% to $74290.0 in Q1 2019 year-over-year; TTM through Feb 2019 was $74290.0, a 69.85% decrease, with the full-year FY2018 number at $5262.0, down 97.5% from a year prior.
  • Finished Goods was $74290.0 for Q1 2019 at Cryo Cell International, up from $5262.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $405096.0 in Q3 2015 to a low of $5262.0 in Q4 2018.
  • A 5-year average of $221165.2 and a median of $246377.0 in 2018 define the central range for Finished Goods.
  • Biggest YoY gain for Finished Goods was 65.6% in 2018; the steepest drop was 97.5% in 2018.
  • Cryo Cell International's Finished Goods stood at $282152.0 in 2015, then fell by 7.5% to $261000.0 in 2016, then fell by 19.21% to $210854.0 in 2017, then crashed by 97.5% to $5262.0 in 2018, then skyrocketed by 1311.82% to $74290.0 in 2019.
  • Per Business Quant, the three most recent readings for CCEL's Finished Goods are $74290.0 (Q1 2019), $5262.0 (Q4 2018), and $168052.0 (Q3 2018).